Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5701 to 5750 of 8214 results

  1. Sequencing and further line treatment:- What is the clinical and cost effectiveness of sequencing and further line treatment in PTSD?

    Recommendation ID NG116/2 Question Sequencing and further line treatment:- What is the clinical and cost effectiveness of sequencing and

  2. Same-day plain X-ray radiology or ultrasound:- What is the clinical and cost effectiveness of providing GPs with access to plain X-ray radiology or ultrasound with same-day results? [See the evidence review on GP access to radiology.]

    Recommendation ID NG94/9 Question Same-day plain X-ray radiology or ultrasound:- What is the clinical and cost effectiveness of providing

  3. Effectiveness of SGLT2 inhibitors for different ethnic groups: What is the clinical and cost effectiveness of SGLT2 inhibitors in adults with type 2 diabetes and chronic kidney disease, stratified across different ethnic groups?

    Recommendation ID NG28/05 Question Effectiveness of SGLT2 inhibitors for different ethnic groups: What is the clinical and cost effectiveness

  4. 'Physician extenders':- What is the clinical and cost effectiveness of providing 'physician extenders' such as advanced nurse practitioners, 'physician associates' and advanced clinical practitioners in secondary care?[See the evidence review on physician extenders.]

    Recommendation ID NG94/15 Question 'Physician extenders':- What is the clinical and cost effectiveness of providing 'physician extenders'

  5. Psychotherapy for chronic primary pain: What is the clinical and cost effectiveness of psychodynamic psychotherapy for managing chronic primary pain in people aged 16 years and over?

    Recommendation ID NG193/8 Question Psychotherapy for chronic primary pain: What is the clinical and cost effectiveness of psychodynamic

  6. Effectiveness of SGLT2 inhibitors for adults with a urine ACR below 3 mg/mmol: What is the clinical and cost effectiveness of SGLT2 inhibitors in adults with type 2 diabetes, chronic kidney disease and a urine ACR of less than 3 mg/mmol?

    Recommendation ID NG28/06 Question Effectiveness of SGLT2 inhibitors for adults with a urine ACR below 3 mg/mmol: What is the clinical

  7. Anticoagulation and antiplatelet therapy: What is the clinical and cost effectiveness of single or dual antiplatelet therapies or anticoagulants compared with placebo after transcatheter or surgical valve replacement (implantation) with biological prosthesis and after valve repair?

    Recommendation ID NG208/22 Question Anticoagulation and antiplatelet therapy: What is the clinical and cost effectiveness of single or

  8. Sleep management strategies: What is the clinical and cost effectiveness of sleep management strategies in managing ME/CFS?

    Recommendation ID NG206/05 Question Sleep management strategies: What is the clinical and cost effectiveness of sleep management strategies

  9. Social interventions for chronic pain, including chronic primary pain: What is the clinical and cost effectiveness of social interventions aimed at improving the quality of life of people aged 16 years and over with chronic pain?

    Recommendation ID NG193/7 Question Social interventions for chronic pain, including chronic primary pain: What is the clinical and cost

  10. Duration of prophylaxis for elective total hip replacement surgery:- What is the clinical and cost effectiveness of standard versus extended duration pharmacological prophylaxis for preventing VTE in people undergoing elective total hip replacement surgery?

    Recommendation ID NG89/5 Question Duration of prophylaxis for elective total hip replacement surgery:- What is the clinical and cost effectiveness

  11. Stepped care for post-traumatic stress disorder:- What is the clinical and cost effectiveness of stepped care for post-traumatic stress disorder (PTSD)?

    Recommendation ID NG116/1 Question Stepped care for post-traumatic stress disorder:- What is the clinical and cost effectiveness of stepped

  12. Stopping anticoagulation after ablation: What is the clinical and cost effectiveness of stopping anticoagulation in people whose atrial fibrillation has resolved after ablation?

    Recommendation ID NG196/3 Question Stopping anticoagulation after ablation: What is the clinical and cost effectiveness of stopping anticoagulation

  13. Stopping anticoagulation after resolution of postoperative atrial fibrillation: What is the clinical and cost effectiveness of stopping anticoagulation in people whose postoperative atrial fibrillation after cardiac surgery has resolved?

    Recommendation ID NG196/4 Question Stopping anticoagulation after resolution of postoperative atrial fibrillation: What is the clinical

  14. Subcutaneous methotrexate:- What is the clinical and cost effectiveness of subcutaneous methotrexate compared with oral methotrexate for adults with early onset RA starting a new DMARD?

    Recommendation ID NG100/6 Question Subcutaneous methotrexate:- What is the clinical and cost effectiveness of subcutaneous methotrexate

  15. Exercise: What is the clinical and cost effectiveness of supervised group and individual exercise compared with unsupervised exercise for people with osteoarthritis?

    Recommendation ID NG226/01 Question Exercise: What is the clinical and cost effectiveness of supervised group and individual exercise compared

  16. Alpha blockers and ureteroscopy- What is the clinical and cost effectiveness of tamsulosin as an adjunct to ureteroscopy?

    Recommendation ID NG118/2 Question Alpha blockers and ureteroscopy- What is the clinical and cost effectiveness of tamsulosin as an adjunct

  17. Monitoring antiseizure medications in women and girls: What is the clinical and cost effectiveness of therapeutic drug monitoring in girls, young women and women with epilepsy?

    Recommendation ID NG217/06 Question Monitoring antiseizure medications in women and girls: What is the clinical and cost effectiveness

  18. Investigations for relatives: What is the clinical and cost effectiveness of investigations to detect intracranial arterial aneurysms in first-degree relatives of people who have had an aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/13 Question Investigations for relatives: What is the clinical and cost effectiveness of investigations to detect

  19. Investigations for babies who may have early-onset infection: What is the clinical and cost effectiveness of laboratory investigations used individually or in combination to exclude early-onset neonatal infection in babies receiving antibiotics for suspected infection?

    Recommendation ID NG195/3 Question Investigations for babies who may have early-onset infection: What is the clinical and cost effectiveness

  20. Laser therapy for chronic primary pain: What is the clinical and cost effectiveness of laser therapy for managing chronic primary pain in people aged 16 years and over?

    Recommendation ID NG193/10 Question Laser therapy for chronic primary pain: What is the clinical and cost effectiveness of laser therapy

  21. What is the clinical and cost effectiveness of lidocaine patches for localised peripheral pain?

    Recommendation ID CG173/9 Question What is the clinical and cost effectiveness of lidocaine patches for localised peripheral pain?

  22. Mandibular advancement splints for severe OSAHS: What is the clinical and cost effectiveness of mandibular advancement splints for managing severe OSAHS?

    Recommendation ID NG202/6 Question Mandibular advancement splints for severe OSAHS: What is the clinical and cost effectiveness of mandibular

  23. Manual therapies for chronic primary pain: What is the clinical and cost effectiveness of manual therapy for managing chronic primary pain in people aged 16 years and over?

    Recommendation ID NG193/3 Question Manual therapies for chronic primary pain: What is the clinical and cost effectiveness of manual therapy

  24. Manual therapy: What is the clinical and cost effectiveness of manual therapy for people with osteoarthritis, when used alone and when in combination with therapeutic exercise?

    Recommendation ID NG226/06 Question Manual therapy: What is the clinical and cost effectiveness of manual therapy for people with osteoarthritis

  25. Medications for mild to moderate nausea and vomiting in pregnancy: What is the clinical and cost effectiveness of medication for women with nausea and vomiting in pregnancy?

    Recommendation ID NG201/2 Question Medications for mild to moderate nausea and vomiting in pregnancy: What is the clinical and cost effectiveness

  26. Earwax:- What is the clinical and cost effectiveness of microsuction compared with irrigation to remove earwax?

    Recommendation ID NG98/2 Question Earwax:- What is the clinical and cost effectiveness of microsuction compared with irrigation to remove earwax

  27. Psychological therapy – mindfulness for chronic primary pain: What is the clinical and cost effectiveness of mindfulness therapy for managing chronic primary pain in people aged 16 years and over?

    Recommendation ID NG193/1 Question Psychological therapy – mindfulness for chronic primary pain: What is the clinical and cost effectiveness

  28. Monitoring and follow-up for adults with hearing loss:- What is the clinical and cost effectiveness of monitoring and follow-up for adults with hearing loss post-intervention compared with usual care?

    Recommendation ID NG98/5 Question Monitoring and follow-up for adults with hearing loss:- What is the clinical and cost effectiveness of

  29. Nimodipine: What is the clinical and cost effectiveness of nimodipine in the management of aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/03 Question Nimodipine: What is the clinical and cost effectiveness of nimodipine in the management of aneurysmal

  30. What is the clinical and cost effectiveness of psychological intervention alone, compared with antipsychotic medication and compared with psychological intervention and antipsychotic medication combined, in young people with first episode psychosis?

    Recommendation ID CG155/4 Question What is the clinical and cost effectiveness of psychological intervention alone, compared with antipsychotic

  31. Oxygen therapy for OSAHS: What is the clinical and cost effectiveness of nocturnal oxygen compared with placebo in people with OSAHS who are unable to tolerate CPAP?

    Recommendation ID NG202/9 Question Oxygen therapy for OSAHS: What is the clinical and cost effectiveness of nocturnal oxygen compared with

  32. Radioactive iodine: What is the clinical and cost effectiveness of RAI after total or completion thyroidectomy for people with T2 disease and no adverse pathological features?

    Recommendation ID NG230/05 Question Radioactive iodine: What is the clinical and cost effectiveness of RAI after total or completion thyroidectomy

  33. Novel endovascular interventions: What is the clinical and cost effectiveness of novel endovascular techniques and devices such as coated coils, endoluminal flow diverters and intrasaccular devices to treat aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/04 Question Novel endovascular interventions: What is the clinical and cost effectiveness of novel endovascular

  34. Anaesthesia: What is the clinical and cost effectiveness of regional versus general anaesthesia on postoperative morbidity in people with hip fracture?

    Recommendation ID CG124/02 Question Anaesthesia: What is the clinical and cost effectiveness of regional versus general anaesthesia on

  35. What is the clinical and cost effectiveness of omega-3 fatty acids in the treatment of children and young people considered to be at high risk of developing psychosis?

    Recommendation ID CG155/2 Question What is the clinical and cost effectiveness of omega-3 fatty acids in the treatment of children and

  36. Relaxation therapy for chronic primary pain: What is the clinical and cost effectiveness of relaxation therapies for managing chronic primary pain in people aged 16 years and over?

    Recommendation ID NG193/9 Question Relaxation therapy for chronic primary pain: What is the clinical and cost effectiveness of relaxation

  37. Follow-up strategies: What is the clinical and cost effectiveness of patient-initiated follow-up compared with routine follow-up for people with osteoarthritis?

    Recommendation ID NG226/04 Question Follow-up strategies: What is the clinical and cost effectiveness of patient-initiated follow-up compared

  38. Relaxation therapies: What is the clinical and cost effectiveness of relaxation therapies for managing primary hypertension in adults in terms of reducing cardiovascular events and improving quality of life?

    Recommendation ID NG136/05 Question Relaxation therapies: What is the clinical and cost effectiveness of relaxation therapies for managing

  39. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of pharmacological management of heart failure for adults with heart failure and severe aortic stenosis, severe aortic regurgitation or severe mitral regurgitation?

    Recommendation ID NG208/18 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

  40. What is the differential impact of interventions that aim to reduce unintended conception and abortion rates among young people aged under 25 years on subgroups of socially disadvantaged young people?

    Recommendation ID PH51/4 Question What is the differential impact of interventions that aim to reduce unintended conception and abortion

  41. Psychologically informed environments: What is the effectiveness and acceptability of clinical psychology-led psychologically informed environments and psychological approaches for people experiencing homelessness?

    Recommendation ID NG214/01 Question Psychologically informed environments: What is the effectiveness and acceptability of clinical psychology-led

  42. Provider incentives: What is the effectiveness and acceptability of giving incentives to providers to increase immunisation rates in the UK?

    Recommendation ID NG218/09 Question Provider incentives: What is the effectiveness and acceptability of giving incentives to providers

  43. Incentives aimed at individuals, family members and carers: What is the effectiveness and acceptability of incentives to increase uptake of routine vaccines in the UK?

    Recommendation ID NG218/02 Question Incentives aimed at individuals, family members and carers: What is the effectiveness and acceptability

  44. Ways of providing advocacy services: What is the effectiveness and acceptability of providing advocacy through different approaches?

    Recommendation ID NG227/01 Question Ways of providing advocacy services: What is the effectiveness and acceptability of providing advocacy

  45. Quasi-mandation of vaccinations: What is the effectiveness and acceptability of quasi-mandation to increase vaccine uptake of routine vaccines?

    Recommendation ID NG218/03 Question Quasi-mandation of vaccinations: What is the effectiveness and acceptability of quasi-mandation to

  46. School-based versus GP-based catch-up campaigns: What is the effectiveness and acceptability of school-based catch-up vaccination sessions compared with GP-based catch-up campaigns in the UK?

    Recommendation ID NG218/10 Question School-based versus GP-based catch-up campaigns: What is the effectiveness and acceptability of school-based